0000898432-23-000827.txt : 20231201 0000898432-23-000827.hdr.sgml : 20231201 20231201161517 ACCESSION NUMBER: 0000898432-23-000827 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patel Gautam CENTRAL INDEX KEY: 0001738054 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 231459687 MAIL ADDRESS: STREET 1: C/O AMNEAL PHARMACEUTICALS LLC STREET 2: 400 CROSSING BLVD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4/A 1 form4.xml FORM 4/A X0508 4/A 2021-12-01 2021-12-01 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001738054 Patel Gautam C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 true true false Class A Common Stock 2021-12-01 4 J 0 3073298 A 15960731 I Footnote On December 1, 2021, an entity controlled by the reporting person was designated as the trustee of a trust that holds 3,073,298 shares of the Class A Common Stock of the issuer. These shares were not previously reported as being beneficially owned by the reporting person due to a clerical error. The reporting person is filing this amendment to the Form 4 filed on December 20, 2021, to include the shares held by the trust in the number of shares reported as being beneficially owned by the reporting person through trusts which the reporting person may be deemed to control. As a result of the error, all Section 16 reports filed by the reporting person after December 20, 2021 understated the number of shares of the Class A Common stock of the issuer beneficially owned by the reporting person by 3,073,298 shares. All such subsequent reports are hereby updated by this amendment. By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. /s/ Gautam Patel 2023-12-01